▼ SELL
$ Value
$77K
Shares
3,020
Price
$26
Filed
Jan 6
Insider
Name
Baumal Caroline
Title
Chief Medical Officer
CIK
0001961100
Roles
Officer
Transaction Details
Transaction Date
2026-01-05
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
91,206
Footnotes
This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 3, 2026. | This includes 925 shares from October 31, 2025 ESPP purchase.
Filing Info
Baumal Caroline's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-22 | APLS | ▼ | $61K |
| 2026-01-20 | APLS | ▼ | $37K |
| 2026-01-05 | APLS | ▼ | $77K |
| 2025-06-09 | APLS | A | $1.6M |
Other Insiders at APLS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Dolsten Mikael | — | — | 2026-02-27 |
|
Watson David O.
General Counsel
|
— | — | 2026-01-28 |
|
Deschatelets Pascal
Chief Scientific Officer
|
— | — | 2026-01-28 |
|
Francois Cedric
Chief Executive Officer
|
— | — | 2026-03-11 |
|
Sullivan Timothy Eugene
Chief Financial Officer
|
— | — | 2026-04-17 |
| O'Brien Stephanie Monaghan | — | — | 2026-04-06 |
|
Nicholson Nur
Chief Technical Officer
|
— | — | 2026-01-28 |
|
Chopas James George
VP/Chief Accounting Officer
|
— | — | 2026-01-28 |
|
DeLong Mark Jeffrey
Chief Business & Strat Officer
|
— | $8K | 2026-02-11 |
|
Boucher Kelley
Chief People Officer
|
— | — | 2026-01-28 |
|
MELTZER LESLIE
Chief Research and Development
|
— | — | 2026-01-28 |